The American Academy of Dermatology has released its first pediatric-specific atopic dermatitis guidelines, addressing key differences in safety, dosing, and care delivery for children. Evidence for ...

Trofinetide offers the first targeted treatment for Rett syndrome, with a new, convenient powdered formulation aimed at significantly reducing adverse effects. Rett syndrome is a severe ...

Switching to donidalorsen led to a 67.6% reduction in monthly HAE attack rates over 1 year, with consistent benefit across prior prophylactic therapies. Most patients achieved or maintained ...

Host Brian Schroer, MD, interviews Sathya Areti, MD, about her case study presented at ACAAI 2025. A 4-year-old boy with recurrent intensive care unit (ICU) admissions for lower respiratory tract ...

Findings from the ELSA study show that population-based screening using a simple dried blood spot test is highly feasible and well accepted by families. In a Contemporary Pediatrics interview, Renuka ...

CRL focused on usability, not efficacy or manufacturing: The FDA’s Complete Response Letter for Anaphylm cited deficiencies limited to human factors, labeling, and a single supportive PK study; no CMC ...

The AAP emphasizes that children’s digital media use must be understood within a broader digital ecosystem that includes caregiver relationships, platform design, and societal systems, not just time ...

New dietary guidelines stress whole foods and reduced processing, with expanded, age-specific guidance for infants, children, and adolescents. According to the agencies, the updated guidelines respond ...

Clinicians now have the first oral alternative to injectable therapy for gonorrhea, a shift Angela Hasler, APRN, CPNP-PC says could ease treatment barriers and improve public health outcomes.

A phase 2b randomized trial found once-weekly navepegritide improved growth velocity, skeletal alignment, and physical functioning in children with achondroplasia. Navepegritide increased annualized ...

FDA approves Kygevvi, the first therapy for thymidine kinase 2 deficiency, a rare mitochondrial disease marked by muscle weakness and early death. The US Food and Drug Administration (FDA) has ...

Results suggest that a single, brief exposure to general anesthesia for surgery is unlikely to impair short-term neurodevelopment in young children. Preliminary results from a randomized clinical ...